TODAY'S HEADLINES
Results of a phase 1b trial of nivolumab combined with ipilimumab demonstrated one- and two-year survival rates of 94 and 88 percent, respectively, in patients with advanced melanoma. » More
|
ADVERTISEMENT
Insights into managing atopic dermatitis and acne
Atopic dermatitis and acne have significant physical, psychosocial and financial impacts on patients. Keep current on the epidemiology and pathogenesis of both conditions and how these may impact patient care  Read More. |
|
New research has led to the discovery of previously unidentified genes that may be responsible for keloid scarring. The findings could lead to more effective treatment methods. » More
|
|
The Food and Drug Administration is requiring black-box warnings on tanning beds, advising the devices shouldn’t be used by those under age 18. » More
|
|
When it comes to isotretinoin, an expert says, patients should not believe everything they read online, while dermatologists should be skeptical about patients’ follow-through regarding birth-control choices. » More
|
|
|
Like
Tweet
